Evidence map›Paper›PMID 41280052›Full record

ArticlebioRxiv : the preprint server for biology2026

Characterize Oral-to-Blood Microbial DNA Translocation in Individuals with Cocaine Use Disorder.

Douglas Johnson, Kamala P Sundararaj, Suganya Subramanian, Yaxin Qiu, Iniyan Samuel, Da Cheng, Tabinda Salman, Zhenwu Luo, Sylvia Fitting, Larry Keen and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Douglas JohnsonDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Kamala P SundararajDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Suganya SubramanianNeurogenomics Laboratory, Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, USA.
Yaxin QiuDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Iniyan SamuelDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Da ChengDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Tabinda SalmanDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Zhenwu LuoDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Sylvia FittingDepartment of Psychology & Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Larry KeenDepartment of Psychology, College of Natural and Health Sciences, Virginia State University, VA 23806, USA.
Elizabeth CallRalph H. Johnson VA Health Care System, Charleston, 29403, USA.
Abhiham MaddiDepartment of Advanced Specialty Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, 29425, USA.
William StoopsDepartments of Behavioral Science, Psychiatry and Psychology, Center on Drug and Alcohol Research, University of Kentucky, Lexington KY, 40536, USA.
Alicia HartleyDivision of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
John E McKinnonDivision of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Zhuang WanDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Stefano BertoDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.
Wei JiangDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, 29425, USA.ORCID 0000-0002-1374-053X

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
The Role of Early Life Stress in Feeding BehaviorsP20GM148302 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jose H Ledo · 2023 to 2026
$11.5M
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis usersR01DA055523 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sylvia Fitting, Wei Jiang · 2022 to 2026
$3.5M
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine UsersR01DA059538 · NIDA · OHIO STATE UNIVERSITY · PI Wei Jiang, Jian Zhu · 2023 to 2026
$2.9M
Impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIVR01DA059854 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Wei Jiang, Zizhang Sheng · 2024 to 2026
$2.1M
Emma Quarles NIDA Diversity Supplement ProposalR15DA052886 · NIDA · VIRGINIA STATE UNIVERSITY · PI KEEN, LARRY D · 2021 to 2025
$901k
NCI NIH HHS P30 CA138313NIDA NIH HHS R01 DA055523NIDA NIH HHS R01 DA059538NIDA NIH HHS R01 DA059854NIDA NIH HHS R15 DA052886NIGMS NIH HHS P20 GM148302
6 · The paper itself

Abstract

Background: Cocaine disrupts gut barriers in animal models, potentially enabling microbial translocation and inflammation in the periphery and central nervous system (CNS), but its direct role in inducing inflammation remains controversial. This study aimed to determine if the oral cavity is a source of circulating microbial DNA translocation in individuals with current cocaine use disorder (CUD). Results: A cross-sectional case-control study was conducted, comparing CUD and demographically matched non-drug controls. Ten CUD (via smoking or vaping) and 24 controls provided paired saliva and blood samples. Microbial 16S rRNA V4 region was sequenced in isolated microbial DNA from saliva and plasma. Single-cell RNA sequencing (scRNAseq) was analyzed in human peripheral blood mononuclear cells. Saliva from CUD, but not plasma, exhibited reduced alpha diversity and altered beta diversity, characterized by enriched Conclusions: This is the first study demonstrating that CUD via smoking or snorting exhibited oral microbial dysbiosis and selective oral-to-blood microbial translocation in vivo. These findings suggest that a compromised oral-to-blood barrier, rather than cocaine itself, promotes immune perturbations in CUD.

Indexed as

cocaine use disorderoral microbiomeoral-to-blood microbial DNA translocation

Identifiers

PMID41280052
PMCPMC12637719

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.